SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, DSPG, LMRK, TRIL; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, DSPG, LMRK, TRIL; Shareholders are Encouraged to Contact the Firm
NEW YORK, Sept. 17, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
紐約9月2021年7月17日/美通社/--全球投資者權益律師事務所Halper Sadeh LLP宣佈，它正在調查以下公司：
ADTRAN, Inc. (NASDAQ: ADTN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with ADVA. Following completion of the transaction, ADTRAN shareholders are expected to own approximately 54% of the combined company. If you are an ADTRAN shareholder, click here to learn more about your rights and options.
Adtran，Inc.(納斯達克：ADTN)可能違反聯邦證券法和/或違反與ADVA合併相關的受託責任。交易完成後，ADTRAN股東預計將擁有合併後公司約54%的股份。如果您是ADTRAN的股東，單擊此處瞭解有關您的權利和選項的更多信息.
DSP Group, Inc. (NASDAQ: DSPG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Synaptics Incorporated for $22.00 per share in cash. If you are a DSP Group shareholder, click here to learn more about your rights and options.
DSP Group，Inc.(納斯達克：DSPG)關於可能違反聯邦證券法和/或違反與其以每股22.00美元現金出售給Synaptics Inc.的受託責任。如果您是DSP集團的股東，單擊此處瞭解有關您的權利和選項的更多信息.
Landmark Infrastructure Partners LP (NASDAQ: LMRK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Landmark Dividend LLC for $16.50 in cash per common unit. If you are a Landmark Infrastructure shareholder, click here to learn more about your rights and options.
Landmark Infrastructure Partners LP(納斯達克：LMRK) 關於可能違反聯邦證券法和/或違反與其以每普通單位16.50美元現金出售給Landmark Divide LLC有關的受託責任。如果您是Landmark Infrastructure的股東，單擊此處瞭解有關您的權利和選項的更多信息.
Trillium Therapeutics Inc. (NASDAQ: TRIL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Pfizer Inc. for $18.50 per share in cash. If you are a Trillium shareholder, click here to learn more about your rights and options.
延齡治療公司(Trillium Treateutics Inc.)納斯達克：Tril)可能違反聯邦證券法和/或違反與其以每股18.50美元現金出售給輝瑞公司相關的受託責任。如果你是Trillium的股東，單擊此處瞭解有關您的權利和選項的更多信息.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Halper Sadeh LLP可能會代表股東尋求增加對價、關於擬議交易的額外披露和信息，或其他救濟和利益。
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
鼓勵股東與公司聯繫。免費討論他們的合法權利和選擇權。請致電丹尼爾·薩德或扎卡里·哈爾珀(Zachary Halper)撥打(212)763-0060或發送電子郵件[受電子郵件保護]或[受電子郵件保護].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Halper Sadeh LLP代表世界各地遭受證券欺詐和公司不當行為受害者的投資者。我們的律師在實施公司改革和代表被欺詐的投資者追回數百萬美元方面發揮了重要作用。
Attorney Advertising. Prior results do not guarantee a similar outcome.
律師廣告。先前的結果並不能保證會有類似的結果。
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
聯繫方式：Halper Sadeh LLP丹尼爾·薩德(Daniel Sadeh)，Esq.扎卡里·哈爾珀(Zachary Halper)，Esq.(212) 763-0060 [受電子郵件保護][受電子郵件保護]Https://www.halpersadeh.com
SOURCE Halper Sadeh LLP
來源：Halper Sadeh LLP
Related Links
相關鏈接
www.halpersadeh.com
Www.halpersadeh.com
譯文內容由第三人軟體翻譯。